Galderma Laboratories, L.P.
Dating back to 1961, Galderma is now present in 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails.
Strategic brands in the U.S. include Cetaphil® and Cetaphil® Baby, Epiduo® Forte Gel, Oracea® Capsules, Clobex® Spray, Differin® Gel, Mirvaso® Gel, Soolantra® Cream, Restylane®, Restylane® Refyne, Restylane® Defyne, Restylane® Silk, Restylane® Lyft, Dysport® (abobotulinumtoxinA), and Sculptra® Aesthetic.
The Dysport® trademark is used under license. All trademarks are the property of their respective owners.
For more information, please visit www.galdermausa.com and www.galderma.com.
All trademarks are the property of their respective owners.
Brands: Cetaphil®, Cetaphil® Baby, Epiduo® Forte Gel, Oracea® Capsules, Differin® Gel, Mirvaso® Gel, Soolantra® Cream